How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Recent cases involve another fraud related to finger prick blood testing, as well as alleged malpractice and discrimination.
These seven strategies can help your small laboratory team overcome challenges to not only succeed, but also thrive.
In order for lab safety training to be effective and lasting, it must be engaging and become part of the lab’s culture.
Tackling recruitment and retention challenges in the clinical laboratory.
What lab leaders should know about the CLIA updates that recently went into effect, and how the changes may impact staffing.
This checklist can help labs monitor their organization’s business arrangements that concern digital pathology to ensure compliance.
Healthcare attorneys explain three digital pathology models for laboratories to be aware of.
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
Ann Lambrix, vice president of RCM Solutions at Lighthouse Lab Services, discusses key developments in lab billing and coding.